XYL

SEC source: 0001209191-19-055461 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-052808 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,228

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $75.49 to $76.37 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-051559 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,514

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019.

F2 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $76.95 to $79.91 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-19-051559 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,518

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019.

SEC source: 0001209191-19-049175 · doc4.xml · derivative · entry 4

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,140

Underlying: Common Stock · 5,000 shares

Expires 2021-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-049175 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,228

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,941 shares were executed at prices ranging from $76.59 to $77.56 per Share. 2,059 shares were executed at prices ranging from $77.61 to $78.28. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-049175 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-044918 · doc4.xml · derivative · entry 4

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,140

Underlying: Common Stock · 5,000 shares

Expires 2021-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-044918 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,228

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,147 shares were executed at prices ranging from $73.94 to $74.89 per Share. 2,149 shares were executed at prices ranging from $74.95 to $75.93. 704 shares were executed at prices ranging from $75.95 to $76.21. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-044918 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-041665 · doc4.xml · derivative · entry 4

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,140

Underlying: Common Stock · 5,000 shares

Expires 2021-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-041665 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,228

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 4,800 shares were executed at prices ranging from $81.64 to $82.61 per Share. 200 shares were executed at prices ranging from $82.65 to $82.97. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-041665 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-041318 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,417

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $82.68 to $83.43 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-040811 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,613

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019.

F3 · price: This price represents the weighted average price per Share of the Issuer, of sales that were executed at prices ranging from $83.95 to $84.68 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price

SEC source: 0001209191-19-040811 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,781

F1 · shares: The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019.

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $83.82 to $84.73 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-039075 · doc4.xml · derivative · entry 7

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,912

Underlying: Common Stock · 3,912 shares

Expires 2027-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options vest in 3 equal annual installments beginning on February 21, 2018.

SEC source: 0001209191-19-039075 · doc4.xml · derivative · entry 6

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,771 shares

Expires 2026-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-039075 · doc4.xml · nonDerivative · entry 5

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,390

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 24, 2019

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at a price of $81.8954 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-039075 · doc4.xml · nonDerivative · entry 4

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,390

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at a price of $81.8954 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-039075 · doc4.xml · nonDerivative · entry 3

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,302

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 24, 2019

SEC source: 0001209191-19-039075 · doc4.xml · nonDerivative · entry 2

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,390

F2 · price: This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at a price of $81.8954 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-039075 · doc4.xml · nonDerivative · entry 1

Brannemo Tomas · CIK 0001607927 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,161

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on May 24, 2019

SEC source: 0001209191-19-035406 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 43,761

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 1,300 shares were executed at prices ranging from $77.71 to $78.68 per Share. An additional 1,044 shares were executed at prices ranging from $78.74 to $79.14. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-034741 · doc4.xml · derivative · entry 4

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,140

Underlying: Common Stock · 5,000 shares

Expires 2021-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-034741 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,228

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 3,700 shares were executed at prices ranging from $74.31 to $75.30 per Share. 1,300 shares were executed at prices ranging from $75.31 to $75.76. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-034741 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-030328 · doc4.xml · nonDerivative · entry 2

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,366

F2 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholder's meeting.

SEC source: 0001209191-19-030840 · doc4.xml · nonDerivative · entry 1

TAMBAKERAS MARKOS I · CIK 0001012990 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 40,670

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

SEC source: 0001209191-19-030827 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,075

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

SEC source: 0001209191-19-030838 · doc4.xml · nonDerivative · entry 1

Peribere Jerome A · CIK 0001484527 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,568

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

SEC source: 0001209191-19-030834 · doc4.xml · nonDerivative · entry 1

Harker Victoria D · CIK 0001350579 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,382

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

SEC source: 0001209191-19-030835 · doc4.xml · nonDerivative · entry 1

LORANGER STEVEN R · CIK 0001226924 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,909

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting event until separation of service.

SEC source: 0001209191-19-030829 · doc4.xml · nonDerivative · entry 1

FRIEL ROBERT F · CIK 0001224110 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,718

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

F2 · balance_after: Additional shares also accrued through a qualified DRIP.

SEC source: 0001209191-19-030836 · doc4.xml · nonDerivative · entry 1

MOHAPATRA SURYA N · CIK 0001222671 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 37,247

F1 · shares: Reflects the award of restricted stock units, which are scheduled to vest on the business day prior to the Xylem Inc. 2020 annual shareholders' meeting.

SEC source: 0001209191-19-030832 · doc4.xml · nonDerivative · entry 1

Gomez Jorge M · CIK 0001726653 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,831

F1 · shares: Reflects the award of restricted stock units which are scheduled to vest the day before the 2020 Annual Shareowner meeting.

SEC source: 0001209191-19-030825 · doc4.xml · nonDerivative · entry 1

Beliveau-Dunn Jeanne · CIK 0001714894 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,550

F1 · shares: Reflects the award of restricted stock units. The Reporting Person elected to defer the vesting of the RSU Award until January 2024.

SEC source: 0001209191-19-030328 · doc4.xml · nonDerivative · entry 1

Jakobsson Sten E · CIK 0001532863 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,535

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incidental to the vesting of stock-settled restricted stock units.

SEC source: 0001209191-19-029568 · doc4.xml · derivative · entry 3

Leung Pak Steven · CIK 0001638493 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,936

Underlying: Common · 8,947 shares

Expires 2025-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-029568 · doc4.xml · nonDerivative · entry 2

Leung Pak Steven · CIK 0001638493 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,033

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $78.50 to $78.65 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-029568 · doc4.xml · nonDerivative · entry 1

Leung Pak Steven · CIK 0001638493 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 42,980

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001209191-19-028198 · doc4.xml · nonDerivative · entry 1

CRAWFORD CURTIS J · CIK 0001014318 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,244

F1 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $79.1910 to $79.2091 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-027942 · doc4.xml · nonDerivative · entry 1

RAJKOWSKI E MARK · CIK 0001258268 · SVP, CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,608

F1 · shares: Reflects the withholding of shares of common stock to pay the tax liability incident to the vesting of restricted stock units granted on May 5, 2016 under the Xylem 2011 Omnibus Incentive Plan.

SEC source: 0001209191-19-027941 · doc4.xml · derivative · entry 4

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,140

Underlying: Common Stock · 5,000 shares

Expires 2021-11-07

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-027941 · doc4.xml · nonDerivative · entry 2

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 41,228

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.01 to $80.83 per Share. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-027941 · doc4.xml · nonDerivative · entry 1

Napolitano Kenneth · CIK 0001531827 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,228

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: These options were exercised and sold pursuant to the Reporting Person's 10b5-1 Plan.

SEC source: 0001209191-19-027190 · doc4.xml · nonDerivative · entry 1

Toussaint Claudia S · CIK 0001421560 · SVP, GC & Corporate Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,105

F1 · shares: These shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on February 4, 2019

F2 · price: This price represents the approximate weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). 2,144 shares were executed at prices ranging from $83.18 to $84.11 per Share. An additional 200 shares were executed at prices ranging from $84.19 to $84.24. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-024453 · doc4.xml · derivative · entry 3

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,930 shares

Expires 2025-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: These options are fully vested and exercisable.

SEC source: 0001209191-19-024453 · doc4.xml · nonDerivative · entry 2

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,613

F2 · price: 4,879 shares were sold at an average execution price of $80.12. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $79.39 to $80.38 per Share. An additional 11,051 shares were sold at an average execution price $80.5939. This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"), of sales that were executed at prices ranging from $80.39 to $80.94 per Share. The weighted average price of both trades is $80.4488. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.

SEC source: 0001209191-19-024453 · doc4.xml · nonDerivative · entry 1

Sabol Colin R · CIK 0001531414 · Senior Vice President

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 54,543

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The exercise and sale were made pursuant to a 10b5-1 plan adopted by the reporting person on March 11, 2019.